chrisvoncsefalvay/vaers-outcomes huggingface dataset:
None, vaccine administration was not recommended due to pregnancy, patient was 7 wks pregnant; EDD 01/04/2022
Started with rash on 09/10/2005 (mom described as a few red bumps) today 09/13/2005 many more itchy.
Knee started hurting again; Tiredness; Headache; Causing incisions to flare up on back; Arm was killing her; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 62-years-old female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0168; Expiration Date: Aug2021), via an unspecified route of administration, administered in Arm Right on 17Jun2021 (at the age of 62 years) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included spinal operation on 13May2021 and COVID-19 (Covid in January). Concomitant medication included paracetamol (TYLENOL). She had back surgery, and her back had been feeling fine then it started hurting her on 17Jun2021. The incisions to flare up on back and it started later on in the day that she had the vaccine. The next day she could tell her back was starting to hurt right when she got out of bed. Her physician said it did not mess with the incision, and it affected whatever was inflamed in her body. He said it should go away. The pain was the same. First her arm was killing her on the day of vaccination and now it was normal. She had it from Thursday all the way to Monday. That started within an hour after getting the vaccine. She just developed like a knot. She had a headache on 18Jun2021 until Sunday (20Jun2021), and she still has back aches. Her knee started hurting again too on an unspecified date. The doctor explained that anywhere that the vaccine would attack anywhere that was already inflamed and cause it to flare up. The patient developed tiredness on 18Jun2021. As far as the tiredness, in the mornings she was still just tired. She had Covid and that was almost what it felt like. She had Covid in January, and the headaches felt like when she got dehydrated with COVID. She started drinking more water because that was exactly how she was feeling. She was still tired and it was the same. She had to motivate herself to get going. Before the shot she was peppy and going, and now she wants to stay in bed. She does get tired. She was getting off of her medications from surgery on the Friday before the shot and that had cleared out of her system and she was starting to feel better. The event outcome for causing incisions to flare up on back was reported as not recovered. On 21Jun2021 the patient recovered from arm was killing her. On 20Jun2021 the patient recovered from headache. The event outcome for knee started hurting again was unknown and event outcome for tiredness was reported as not recovered.   Follow up attempts are possible. Further information is expected.
i got a rash on the right leg; This is a spontaneous report from a contactable consumer (Patient) via COVID-19 Adverse Event Self-Reporting.  A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, batch/Lot Number: EN6198), via an unspecified route of administration, administered in right arm on an unknown date in FEB-2021 at 12:00 PM, (age at the time of vaccination: 74-year-old) as DOSE 1, SINGLE for COVID-19 immunisation administered in Health Clinic. Medical history included penicillin allergy from an unknown date and unknown if ongoing (Known Allergies: Penyciline as reported), allergy to Insect bites (big time) from an unknown date and unknown if ongoing, deodorant allergy (Dehodorants as reported) from an unknown date and unknown if ongoing. The patient concomitant medication(s) included tadalafil (CIALIS), atorvastatin (ATORVASTATIN), ageless male (AGELESS MALE) and loratadine (CLARITINE) for an unknown indication and start and stop dates not reported. The patient did not received other vaccine in four weeks. There were no covid prior to vaccination and not being tested for covid post vaccination. On an unknown date in Mar2021, the patient got a rash on the right leg. Adverse event resulted into physician office visit to the patient. Treatment not received for the event. The clinical outcome of the event was not recovered.  No Follow-up attempts are needed. No Further information is expected.
Information has been received from a pharmacist concerning a patient who in August 2009, "3-4 weeks ago" was vaccinated with ZOSTAVAX (Merck), (lot # reported as 659054/0315Y valid for GARDASIL). It was reported that approximately on 20-AUG-2009, "1 week ago", the patient experienced shingles. At the time of the report, the patient's outcome was unknown. The patient spoke to pharmacist. Follow-up information has been received from a physician indicating that the patient was a 84 year old female, weighing 149 pounds and 5' 7" inches in height, with allergy to ELAVIL (WAES # 0909USA04132) and a medical history of chickenpox, who on 20-MAR-2009 (previously reported as in August 2009, "3-4 weeks ago" from the reporting date by the pharmacist) was vaccinated with the first dose of ZOSTAVAX (Merck) (Lot # 663895/0135Y). The patient had not been exposed to chickenpox or herpes zoster recently. The physician reported that the patient experienced rash on 08-APR-2009. On 23-JUN-2009, the patient complained of itching and the rash lessened. On 26-AUG-2009, the patient experienced herpes zoster ophthalmologic (previously reported as approximately 20-AUG-2009, "1 week ago" from the reporting date by the pharmacist). As of 15-SEP-2009, the patient was still recovering. Rash, itching and herpes zoster ophthalmologic were considered to be an other important medical event by the reporter. Additional information has been requested.
Injection site swelling, tender. Back, neck and stomach ached. Started on Saturday and persisted in Sunday with improvement therafter
a facility administered this expired vaccine to up to 70 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a facility administered this expired vaccine to up to 70 patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (a facility administered this expired vaccine to up to 70 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (a facility administered this expired vaccine to up to 70 patients) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information or concomitant medications were provided.  Nurse stated that a facility administered this expired vaccine to up to 70 patients.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Followup received on 28-June-2021 and reporter details has been updated
A week after I started having a burning sensation on upper back, feet, and limbs and everywhere, it's getting worse.  It's been a month and a half and it's not going away they couldn't do anything at the ER but said it would work itself out.   I got the 2nd dose on 3/31/2021 Lot number EP6955
Shingles occurred occurred several months after receiving vaccine. Resolved in December 2016.  MD wanted to report.
Information has been received from two healthcare workers referring to a patient of unknown age and gender. The patient's medical history was not reported. On 06-FEB-2015 the patient was received improperly stored VARIVAX (Merck) (lot # K007979, expiration date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
flu shot at young age in her 50's and was so sick; Initial information received on 19-Feb-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves a 50 years old and unknown gender patient who experienced flu shot at young age in her 50's and was so sick while receiving vaccine Influenza USP Trival A-B Subvirion no preservative Vaccine [Fluzone].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza USP Trival A-B Subvirion no preservative Vaccine  suspension for injection (strength: unknown)at unknown dosage (lot number & expiry date: unknown)in unknown administration site for immunization. Information on batch number is requested.  On an unknown date the patient developed a non-serious flu shot at young age in her 50's and was so sick (illness) (unknown latency) following the administration of Influenza USP Trival A-B Subvirion no preservative Vaccine.    Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event illness.  At time of reporting, the outcome was Unknown for the event illness.
my hives were getting very irritating; little rashes and kind of hives on my body; growing inwards; little rashes and kind of hives on my body; growing inwards; itching and hives on my wrist and my feet and it's like kind of growing toward my back; rashes I mean it's kind of red; This is a spontaneous report from a contactable consumer, the patient. This 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733; Expiration Date: 31Jul2021), via an unspecified route of administration on 26Mar2021 (at the age of 24-year-old) as single dose for COVID-19 immunization. The patients medical history and concomitant medications were not reported. The patient stated, "I wanted to call and report side effects so I got my vaccine on the 26Mar2021 and since Sunday (18Apr2021) I have been getting like little rashes and kind of hives on my body so started on my wrist just like growing inwards. Just wanted to report like it was itching and hives on my wrist and my feet and it's like kind of growing towards my back as well so I mean I can breath and everything, it's not like that I have like an anaphylactic reaction but I can, like it's very itchy and irritating. I am still getting like hives and rashes I mean it's kind of red, but it still growing a little bit. I did take like one antihistamine Zyrtec 10 mg only once a day yesterday (20Apr2021) for the little rashes and kind of hives, because my hives were getting very irritating. My second shot is scheduled for this Friday that's on 23Apr2021." Patient reported his height as 6 feet 1 inch (185 cm) and weight should be like 190 pounds on an unspecified date. The clinical outcomes of the events, "rashes I mean it's kind of red", "little rashes and kind of hives on my body; growing inwards", "itching and hives on my wrist and my feet and it's like kind of growing toward my back" and "my hives were getting very irritating" were not resolved as of 21Apr2021.
Pt became very dizzy. Disoriented with nausea. Requested to Dr. Taken to ER where they observed and released.
Hand, foot and mouth disease.  Patient started feeling unwell on 7/23, on 7/24 he got a fever and we took him to ER on 7/25 after tylenol and ibuprofen failed to bring down his fever significantly.  In ED, he did not get a physical examination by MD, they did a respiratory test which showed positive rhinovirus/enterovirus (test could not differentiate), and we were sent home stating it was  likely a rhinovirus.  That night patient developed rash all over his legs and feet, and some on hands and feet.  i sent the picture to the pediatrician, and asked for medications, which she wrote.
Very heavy menstrual bleeding. Bled through clothing and bedding. Lasted 2x as long as all previous months. Similar but not as heavy, occurred in May 2021 (second menses cycle since receiving vaccine).
11/15/2004, Received flu shot, 11/16/04, achy, cough, congested head, 11/17/04 diarrhea, head cold changed to chest cold. Cough up phlegm, tired/hot, 11/18/04 felt better, continued with cough, 11/19/04 diarrhea returned, hot, no upset stomach, 11/19/04 woke up hot, burning up with slight diaphoresis. Does not have a thermometer. Called her provider on 11/18/2004.
The patient received a Moderna vaccine on 08/31/2021. On 09/23/21 the patient received a Pfizer vaccine as noted above.
LACK OF EFFECT; TESTED POSITIVE FOR COVID; This spontaneous report received from a patient concerned a 35 year old male unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808960 expiry: UNKNOWN) dose was not reported,1 total administered to right deltoid on JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient tested positive for covid (lack of effect). Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tested positive for covid and lack of effect was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210952834- JANSSEN COVID-19 VACCINE Ad26.COV2.S- Lack of effect. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
After getting vaccine patient left room to go wait 15 minutes in lobby.  Stood from chair and walked 30feet across lobby and felt like he was going to pass out sat in chair with head between knees and passed out briefly. Gave pt water to sip and he asked for a type of sugar and was given orange juice. 4:36 still didn't feel well and was nauseated. Pt attributed it to the feeling after passing out. Still dizzy and off so gave diphenhydramine 25mg cap po. Minutes after taking diphenhydramine patient vomited in the trash can. I moved him back to the vaccine room to sit under observation. He reported his stomach felt better. Observed patient until 5pm. Patient reported feeling better and was escorted to his car by manager. I asked pt to sit in car and make sure he was ok before driving. Pt called at 5:43 to report he made it home safely and was feeling better. He also asked how to schedule his next vaccine.
Subarachnoid hemorrhage. Was in icu from 4/8/2021 until 4/15/2021
Tightness in chest on 1/20/2013 along with paresthesia in hands and feet bilateral. Redness in hands, particularly around old hand fracture. Steroids and BENADRYL given at onset of symptoms; continued 2 steroid taper dose packs. No symptoms reported on 1/28/2013 - finished steroids.
Swelling, redness, itching and rash at the injection site.  Fever and chills.
1050: Pt in waiting lot after receiving 2nd dose of Pfizer vaccine.  Reported to attendant sensation of throat tightening. RN and NG medic responded to vehicle.  Pt calm, talking, no appearance of distress. States "feels like my mask is too tight".  Also states tongue feels different.  Denies itching, denies SOB.  1054: VS stable.  1057:  Med Officer contacted. Advised Benadryl 25mg po per s.o./ med administered.  MD also instructed pt to take home med of ProAir on arrival home and be sure to take Singulair tonight.  Pt advised.  No further progression of symptoms.  Pt left lot @ 1115.  RN f/u with ph call @ 1335.  Pt home, reported symptoms have resolved.  No further complaints.
Unexpected therapeutic benefit; This case was reported by a consumer via call center representative and described the occurrence of unexpected therapeutic effect in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included post herpetic neuralgia.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced unexpected therapeutic effect. On an unknown date, the outcome of the unexpected therapeutic effect was unknown.   It was unknown if the reporter considered the unexpected therapeutic effect to be related to Shingrix.  Additional details were received as follows: The age vaccination was not reported. The reporter stated that she had a friend who described that her grandmother experienced a reduction in post herpetic neuralgia from a shingles outbreak after receiving the Shingrix vaccine, which led to unexpected therapeutic effect. The reporter was unable to provide any additional information. This was one of the 4 cases, reported by the same reporter. This case has been linked with case US2019125903, US2019125910, US2019125912, reported by the same reporter.
Patient called. She was seen on 2/16 for her second COVV. On 2/19 she started getting an itchy red area that was warm to touch it was around 6 inches long not at the injection site but below and extended to the elbow. She treated the area with cortisone cream and cool compresses and it is almost cleared up.
I started to not feel great. I was having fever, deep congestion, body ache and headache. It a lot of postnasal drip. I tested at home it was COVID-19 positive. I was in bed for mostly two days. I didn't have the strength to eat anything. It was horrible, but it was comfortable either. I had a fever and contacted Telehealth and I was prescribed Paxlovid. I felt better after two days of the five days.  I started feeling better after the new year. On 01/02/2023 I tested, and I was negative and went to get outside and all that week. I did go basketball and I contracted COVID-19 again on that Friday night. I was getting a very runny nose and sneezing and a slight sore throat. I tested again at home it was positive again. I called my doctor again and tested again at a mobile site.  I was negative for Flu and my sinuses were inflamed with an infection and I was prescribed an antibiotic for 4 days.  I feel better but not clear. I tested on this Monday 01/15/2022, and it was negative.
Information has been received from an agency representing a pharmacy in regards to a male patient who in approximately November 2013, received a dose of ZOSTAVAX (lot # J006830, expiration 14-SEP-2014) (exact date of administration, site and dose not reported). It was reported that on 02-NOV-2013, the patient was hospitalized shortly after receiving his dose of ZOSTAVAX. The reason for the hospitalization was not reported. No medical history was provided. No additional information was reported. Additional information is not expected.
1hr p/vax pt devel generalized urticaria rash;no systemic anaphylaxis;
I had a scratchy throat & a runny nose. I also had a bad case of nasal congestion.
No additional adverse event (AE); A pediatric dose of VAQTA with a labeled expiry of 10/1/2022 was administered to a patient on 10/3/2022.; This spontaneous report was received from a nurse and refers to a unknown age and gender patient. No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided.  On 03-0CT-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) at a dose of 0.5 mililiter (ml), lot number 1792241, expiration date: 01-OCT-2022, who had been verified to be a valid number, administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). No additional adverse event was reported.
Persistent Headaches, occur every day since 72 hours after infection 2. Can treat with OTC meds but continue to be present
11-28-2016 Patient received HPV #2, from these he progressively developed generalized muscle weakness/pain to the point of becoming wheelchair bearer.
At the time indicated (December 9th, ~05:00pm; roughly 48 hours after receiving my Moderna COVID booster shot) I noticed itchy red areas on the top of my left hand. later that evening (December 9th, ~08:00pm) I noticed a roughly round shaped , ca. 5cm in diameter area on my right thigh that appeared very red and slightly itchy. This morning the area had turned a darker shade of red leaning towards purple. The area feels warm, slightly itchy and mildly tender when I push on it. The rest of the skin on my body also feels slightly sensitized or itchy, but no redness outside the area on my thigh. This is still ongoing as of now (December 10th, 2pm).
Tested positive for Chlamydia; A spontaneous report was received from a pharmacist on 13APR2023 regarding a 19-year-old female patient who was "tested positive for chlamydia" (PT: Chlamydial infection) following the administration of Vivotif capsule (Typhoid vaccine live oral Ty21A; lot number: unknown) for immunisation.    The patient's medical history, concomitant medications, or known allergies were reported as none.  On 12APR2023 the patient received one dose of Vivotif and was tested positive for chlamydia during an unrelated sexually transmitted disease (STD) screen. Reportedly, the patient was asymptomatic and did not receive any treatment for chlamydia. Additionally, it was reported that the patient has not decided whether she would continue the Vivotif or would stop the medication.  The outcome of the reported event was unknown, at the time of this report.   The action taken with Vivotif with respect to the reported event was unknown.    No additional information was reported.  Company comment: It was reported that a 19-year-old female patient tested positive for chlamydia (chlamydial infection) following the administration of first dose of Vivotif for immunisation. Considering the information reported, it seems to be an incidental finding on STD screening and the patient was asymptomatic, the causality for the event chlamydial infection is assessed as not related to Vivotif. The case is considered serious due to the medical significance of the event.  Updated Company Comment: A spontaneous case report regarding a 19-year-old female consumer with no reported medical history, and concomitant medications, who tested positive for chlamydia, during an unrelated sexually transmitted disease screen following the first dose of Vivotif. The patient was asymptomatic and did not receive any treatment for chlamydia. It is unknown if Vivotif will be continued. The outcome of the event was not reported. The causality of the incidental event is assessed as not related to Vivotif given the lack of biological plausibility.; Sender's Comments: A spontaneous case report regarding a 19-year-old female consumer with no reported medical history, and concomitant medications, who tested positive for chlamydia, during an unrelated sexually transmitted disease screen following the first dose of Vivotif. The patient was asymptomatic and did not receive any treatment for chlamydia. It is unknown if Vivotif will be continued. The outcome of the event was not reported. The causality of the incidental event is assessed as not related to Vivotif given the lack of biological plausibility.
severe chills, fever, severe aches, joint pain - hacking cough, chest tightness
Mom started to notice hives on the patients body and swelling of the hands and feet at around 9pm on 10/10/2023. Mom took patient to the nearest emergency department where they were given Benadryl and told to follow up with PCP. Patient was seen today 10/11/2023 and hives were still noted on face, arms, and legs as well and swelling to hands and feet. Patient advised to continue Benadryl every 8 hours and to go back to the emergency department if the rash becomes worse or patient develops any trouble breathing.